CA2497246A1 - Neoadjuvant treatment of breast cancer - Google Patents

Neoadjuvant treatment of breast cancer Download PDF

Info

Publication number
CA2497246A1
CA2497246A1 CA002497246A CA2497246A CA2497246A1 CA 2497246 A1 CA2497246 A1 CA 2497246A1 CA 002497246 A CA002497246 A CA 002497246A CA 2497246 A CA2497246 A CA 2497246A CA 2497246 A1 CA2497246 A1 CA 2497246A1
Authority
CA
Canada
Prior art keywords
administered
patient
administration
amount
chemotherapeutic agent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002497246A
Other languages
English (en)
French (fr)
Inventor
Lorne J. Brandes
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Manitoba
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2497246A1 publication Critical patent/CA2497246A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Prostheses (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
CA002497246A 2002-09-03 2003-09-02 Neoadjuvant treatment of breast cancer Abandoned CA2497246A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US40724202P 2002-09-03 2002-09-03
US60/407,242 2002-09-03
PCT/CA2003/001335 WO2004022163A1 (en) 2002-09-03 2003-09-02 Neoadjuvant treatment of breast cancer

Publications (1)

Publication Number Publication Date
CA2497246A1 true CA2497246A1 (en) 2004-03-18

Family

ID=31978443

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002497246A Abandoned CA2497246A1 (en) 2002-09-03 2003-09-02 Neoadjuvant treatment of breast cancer

Country Status (9)

Country Link
US (2) US20060160755A1 (https=)
EP (1) EP1545709B1 (https=)
JP (1) JP2006516532A (https=)
KR (1) KR20060039387A (https=)
AT (1) ATE378089T1 (https=)
AU (1) AU2003269621A1 (https=)
CA (1) CA2497246A1 (https=)
DE (1) DE60317537T8 (https=)
WO (1) WO2004022163A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201121924D0 (en) * 2011-12-20 2012-02-01 Fahy Gurteen Labs Ltd Detection of breast cancer

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5798339A (en) * 1990-12-17 1998-08-25 University Of Manitoba Treatment method for cancer
US5618846A (en) * 1990-12-17 1997-04-08 University Of Manitoba Treatment method for cancer
US5616846A (en) * 1994-10-27 1997-04-01 Kwasnik; Joseph W. Method and apparatus for current regulation and temperature compensation
PL369792A1 (en) * 2001-11-01 2005-05-02 Ym Biosciences, Inc. Use of n,n-diethyl-2-[-4-(phenylmethyl)-phenoxy]ethanamine monohydrochloride (dppe) in cancer therapy
US20050119263A1 (en) * 2001-11-09 2005-06-02 Vincent Mark D. Treatment of breast cancer

Also Published As

Publication number Publication date
DE60317537T8 (de) 2009-02-05
DE60317537T2 (de) 2008-10-23
EP1545709B1 (en) 2007-11-14
EP1545709A1 (en) 2005-06-29
US20080318880A1 (en) 2008-12-25
KR20060039387A (ko) 2006-05-08
ATE378089T1 (de) 2007-11-15
WO2004022163A1 (en) 2004-03-18
JP2006516532A (ja) 2006-07-06
US20060160755A1 (en) 2006-07-20
DE60317537D1 (de) 2007-12-27
AU2003269621A1 (en) 2004-03-29

Similar Documents

Publication Publication Date Title
AU2003244646B2 (en) Use of docetaxel/doxorubicin/cyclophosphamide in adjuvant therapy of breast and ovarian cancer
JP2001247459A (ja) 癌の組み合わせ療法
JP2006523664A5 (https=)
EP1545709B1 (en) Neoadjuvant treatment of breast cancer
CA2179377C (en) Method of treatment of hormone-unresponsive metastatic prostate cancer
EP1441711A1 (en) Treatment of breast cancer
CA2497879A1 (en) Use of a combination of dppe with other chemotherapeutic agents for the treatment of breast cancer
JP7311177B2 (ja) Ａ－ＮＯＲ－５αアンドロスタン薬物と抗がん薬物との併用
WO2004022044A1 (en) Use of a combination of a taxane with dppe for the treatment of cancer
JP2017226643A5 (https=)
EP1536779A2 (en) Treatment of metastatic breast cancer with anthracyclines and taxanes
Bauer et al. Adjuvant and neoadjuvant chemoradiation therapy for primary colorectal cancer
CN106668061B (zh) 一种含有顺铂的抗癌药物组合物
CN120420332A (zh) 一种含mTOR抑制剂的组合物及其用途
AU2002340668A1 (en) Treatment of breast cancer
Kaburagi et al. Alternative daily subcutaneous injections of4ig/kg lenograstim in lung cancer case

Legal Events

Date Code Title Description
EEER Examination request
FZDE Discontinued